Logo image of POAI

PREDICTIVE ONCOLOGY INC (POAI) Stock Fundamental Analysis

NASDAQ:POAI - Nasdaq - US74039M3097 - Common Stock - Currency: USD

0.79  -0.01 (-1.25%)

After market: 0.7847 -0.01 (-0.67%)

Fundamental Rating

2

Taking everything into account, POAI scores 2 out of 10 in our fundamental rating. POAI was compared to 187 industry peers in the Health Care Equipment & Supplies industry. POAI has a bad profitability rating. Also its financial health evaluation is rather negative. POAI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

POAI had negative earnings in the past year.
POAI had a negative operating cash flow in the past year.
POAI had negative earnings in each of the past 5 years.
In the past 5 years POAI always reported negative operating cash flow.
POAI Yearly Net Income VS EBIT VS OCF VS FCFPOAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

POAI's Return On Assets of -185.55% is on the low side compared to the rest of the industry. POAI is outperformed by 92.51% of its industry peers.
Industry RankSector Rank
ROA -185.55%
ROE N/A
ROIC N/A
ROA(3y)-150.57%
ROA(5y)-139.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
POAI Yearly ROA, ROE, ROICPOAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K -5K -10K -15K -20K

1.3 Margins

With a Gross Margin value of 49.08%, POAI perfoms like the industry average, outperforming 44.38% of the companies in the same industry.
In the last couple of years the Gross Margin of POAI has declined.
The Profit Margin and Operating Margin are not available for POAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.14%
GM growth 5Y-4.67%
POAI Yearly Profit, Operating, Gross MarginsPOAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

0

2. Health

2.1 Basic Checks

POAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for POAI has been increased compared to 1 year ago.
Compared to 5 years ago, POAI has more shares outstanding
POAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
POAI Yearly Shares OutstandingPOAI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
POAI Yearly Total Debt VS Total AssetsPOAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -48.49, we must say that POAI is in the distress zone and has some risk of bankruptcy.
POAI has a Altman-Z score of -48.49. This is amonst the worse of the industry: POAI underperforms 95.72% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -48.49
ROIC/WACCN/A
WACC9.02%
POAI Yearly LT Debt VS Equity VS FCFPOAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

POAI has a Current Ratio of 0.76. This is a bad value and indicates that POAI is not financially healthy enough and could expect problems in meeting its short term obligations.
POAI has a worse Current ratio (0.76) than 91.98% of its industry peers.
A Quick Ratio of 0.75 indicates that POAI may have some problems paying its short term obligations.
POAI's Quick ratio of 0.75 is on the low side compared to the rest of the industry. POAI is outperformed by 88.77% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.75
POAI Yearly Current Assets VS Current LiabilitesPOAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

5

3. Growth

3.1 Past

POAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.28%, which is quite impressive.
The Revenue for POAI has decreased by -31.48% in the past year. This is quite bad
The Revenue has been growing slightly by 2.86% on average over the past years.
EPS 1Y (TTM)50.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.26%
Revenue 1Y (TTM)-31.48%
Revenue growth 3Y4.57%
Revenue growth 5Y2.86%
Sales Q2Q%-73.72%

3.2 Future

The Earnings Per Share is expected to grow by 28.66% on average over the next years. This is a very strong growth
Based on estimates for the next years, POAI will show a very strong growth in Revenue. The Revenue will grow by 158.10% on average per year.
EPS Next Y93.75%
EPS Next 2Y42.77%
EPS Next 3Y28.66%
EPS Next 5YN/A
Revenue Next Year569.48%
Revenue Next 2Y232.87%
Revenue Next 3Y158.1%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
POAI Yearly Revenue VS EstimatesPOAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
POAI Yearly EPS VS EstimatesPOAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -10 -20 -30

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for POAI. In the last year negative earnings were reported.
POAI is valuated reasonably with a Price/Forward Earnings ratio of 9.68.
Compared to the rest of the industry, the Price/Forward Earnings ratio of POAI indicates a rather cheap valuation: POAI is cheaper than 93.58% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of POAI to the average of the S&P500 Index (21.76), we can say POAI is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 9.68
POAI Price Earnings VS Forward Price EarningsPOAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
POAI Per share dataPOAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
POAI's earnings are expected to grow with 28.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.77%
EPS Next 3Y28.66%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for POAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PREDICTIVE ONCOLOGY INC

NASDAQ:POAI (7/11/2025, 8:00:00 PM)

After market: 0.7847 -0.01 (-0.67%)

0.79

-0.01 (-1.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-12 2025-08-12
Inst Owners2.08%
Inst Owner Change0%
Ins Owners1.27%
Ins Owner Change0%
Market Cap7.05M
Analysts43.33
Price Target3.06 (287.34%)
Short Float %1.19%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-132.24%
Min EPS beat(2)-270.37%
Max EPS beat(2)5.88%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-10.68%
Min Revenue beat(2)-92.79%
Max Revenue beat(2)71.43%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.68
P/S 5.24
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.82
EYN/A
EPS(NY)0.08
Fwd EY10.33%
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)-1.04
OCFYN/A
SpS0.15
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -185.55%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.08%
FCFM N/A
ROA(3y)-150.57%
ROA(5y)-139.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.14%
GM growth 5Y-4.67%
F-Score3
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.25%
Cap/Sales 0.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.75
Altman-Z -48.49
F-Score3
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)20.65%
Cap/Depr(5y)33.78%
Cap/Sales(3y)11.77%
Cap/Sales(5y)26.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.26%
EPS Next Y93.75%
EPS Next 2Y42.77%
EPS Next 3Y28.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-31.48%
Revenue growth 3Y4.57%
Revenue growth 5Y2.86%
Sales Q2Q%-73.72%
Revenue Next Year569.48%
Revenue Next 2Y232.87%
Revenue Next 3Y158.1%
Revenue Next 5YN/A
EBIT growth 1Y32.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.86%
OCF growth 3YN/A
OCF growth 5YN/A